Neuroblastoma
Not yet recruitingFeasibility Study of AloCelyvir and Autologous Tumor‑Infiltrating T Lymphocytes in Children and Young Adults with High‑Risk Relapsed/Refractory Neuroblastoma
Feasibility Study of AloCelyvir and Autologous Tumor‑Infiltrating T Lymphocytes in Children and Young Adults with High‑Risk Relapsed/Refractory Neuroblastoma
- Disease:Neuroblastoma
- Substances:aloCELYVIRAUTOLOGOUS TUMOR-INFILTRATING T LYMPHOCYTES, EX VIVO EXPANDED WITH INTERLEUKIN-7, INTERLEUKIN-15 AND INTERLEUKIN-21
Spain- Participants:0–17 years · 18–64 years
- Substances:aloCELYVIR







